Medpace Holdings, Inc.
Beyond Air (XAIR) director bought $56,590 in shares, Compass Therapeutics (CMPX) CFO acquired $18,400 in stock, Sky Harbour (SKYH) CFO purchased $15,040 in shares. CrowdStrike (CRWD) president sold $64M, Medpace (MEDP) CEO sold $30M, Snowflake (SNOW) director sold $17M. Insider trades may indicate confidence or tax obligations.
Medpace Holdings Inc (MEDP) shares fell 4.2% to $598.08, within a 52-week range of $373.00 to $677.90. The stock is overvalued by 11.3% according to GF Value™, with a GF Score™ of 97/100. Insiders sold $436.7M in shares over the past year, with no purchases. The P/E ratio is 35.1x, above its 5-year median of 31.5x.
Medpace's President & CEO August J. Troendle sold 49,100 shares in two transactions on 2026-09-29 and 2026-09-30, totaling $30.3M. He now directly owns 338,225 shares and indirectly owns 4.7M shares via Medpace Investors, LLC, according to SEC filings.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning MEDP (Medpace Holdings, Inc.). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent MEDP coverage spans insider activity, financial news and market movers.
In the last 30 days, MEDP insiders filed 11 SEC Form 4 transactions — no purchases and 11 sales ($125.9M). The most active reporter was Troendle August J., President & CEO, with 11 filings.
Negative sentiment for MEDP.
The stock is likely to face continued downside pressure.
Medpace's President & CEO August J. Troendle sold 49,100 shares in two transactions on 2026-09-29 and 2026-09-30, totaling $30.3M. He now directly owns 338,225 shares and indirectly owns 4.7M shares via Medpace Investors, LLC, according to SEC filings.
Large insider sale may signal reduced confidence and put downward pressure on the stock.
Analyst rating and higher price target may attract buying interest, but overvaluation concerns could limit upside.
AlphAI scores every news story that mentions MEDP with an AI model for sentiment and relevance, and aggregates insider trades from Medpace Holdings, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Beyond Air (XAIR) director bought $56,590 in shares, Compass Therapeutics (CMPX) CFO acquired $18,400 in stock, Sky Harbour (SKYH) CFO purchased $15,040 in shares. CrowdStrike (CRWD) president sold $64M, Medpace (MEDP) CEO sold $30M, Snowflake (SNOW) director sold $17M. Insider trades may indicate confidence or tax obligations.
3 min readMedpace Holdings Inc (MEDP) shares fell 4.2% to $598.08, within a 52-week range of $373.00 to $677.90. The stock is overvalued by 11.3% according to GF Value™, with a GF Score™ of 97/100. Insiders sold $436.7M in shares over the past year, with no purchases. The P/E ratio is 35.1x, above its 5-year median of 31.5x.
2 min readMedpace's President & CEO August J. Troendle sold 49,100 shares in two transactions on 2026-09-29 and 2026-09-30, totaling $30.3M. He now directly owns 338,225 shares and indirectly owns 4.7M shares via Medpace Investors, LLC, according to SEC filings.
1 min readTroendle August J. (President & CEO) sold 48,667 shares of Medpace Holdings, Inc. (MEDP) at an average of $623.03 ($621.02–$625.47, $30.32M total) across 2 trades over 2026-09-29 to 2026-09-30.
1 min readUBS resumed coverage of Medpace (MEDP) with a Neutral rating and $673 price target, citing high valuation but reasonable growth expectations. The company reported strong Q2 2026 results, with revenue up 17.2% YoY and EPS up 37.1%. Analysts have mixed outlooks, with some raising targets and others expressing caution about future revenue growth.
2 min readTroendle August J. (President & CEO) sold 2,564 shares of Medpace Holdings, Inc. (MEDP) at an average of $620.10 ($620.07–$620.60, $1.59M total) across 2 trades over 2026-09-25 to 2026-09-28.
1 min readMedpace Holdings CEO August J. Troendle sold 10,880 shares for $6.75m at $620.4 average price. He now holds 504,273 shares directly and 4.7m indirectly. Medpace's Q2 2026 earnings beat expectations with $4.25 EPS and $707.3m revenue, up 37.1% and 17.2% YoY. Analysts adjusted price targets: BMO to $600, Jefferies to $560, TD Cowen to $492.
2 min readTroendle August J. (President & CEO) sold 43,916 shares of Medpace Holdings, Inc. (MEDP) at an average of $624.01 ($621.33–$628.64, $27.40M total) across 2 trades over 2026-09-23 to 2026-09-24.
1 min readTroendle August J. (President & CEO) sold 70,901 shares of Medpace Holdings, Inc. (MEDP) at an average of $626.62 ($623.29–$628.11, $44.43M total) across 2 trades over 2026-09-21 to 2026-09-22.
1 min readTroendle August J. (President & CEO) sold 10,880 shares of Medpace Holdings, Inc. (MEDP) at $620.40 ($6.75M total) on 2026-09-17.
1 min read
